Stockholm - Free Realtime Quote SEK

AroCell AB (publ) (AROC.ST)

Compare
0.5550
-0.0500
(-8.26%)
As of 4:12:03 PM GMT+1. Market Open.

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
NameTitlePayExercisedYear Born
Mr. Anders Hultman B.Sc. Chief Executive Officer -- -- 1974
Jonas Söderholm Global Medical Lead -- -- --
Ms. Maria Sundberg Chief Operations Officer -- -- --
Mr. Kiran Kumar Jagarlamudi Ph.D. Director of Business Development -- -- 1982
Mr. Gustav Sten Chief Marketing Officer -- -- --
Ms. Jocelyn Akerberg Chief Quality Officer -- -- --

AroCell AB (publ)

KarlsbodavAegen 39
Bromma
Stockholm, 168 67
Sweden
46 87 99 67 50 https://www.arocell.com
Sector: 
Healthcare
Full Time Employees: 
22

Description

AroCell AB (publ), a vitro diagnostics company, develops and markets blood and urine sample test products for use in the treatment of breast, prostate, and bladder cancers. The company provides AroCell TK 210 ELISA, an immunoassay kit for the determination of human Thymidine Kinase 1 protein concentration in blood samples; and UBC Rapid for diagnosing and monitoring bladder cancer patients. It also offers TUBEX TF, an in vitro diagnostic test for the detection of acute typhoid fever. The company was formerly known as Xi Bao Research AB and changed its name to AroCell AB (publ) in 2006. AroCell AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.

Corporate Governance

AroCell AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events